Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
PHYSICIANS HEALTHSOURCE, INC. v. ENDO PHARMACEUTICALS, INC. et al
Case Number:
2:14-cv-02289
Court:
Nature of Suit:
Other Statutes: Other Statutory Actions
Multi Party Litigation:
Class Action
Judge:
Firms
Companies
Sectors & Industries:
-
August 28, 2015
Endo Wants TCPA Suit Held Longer While FCC Mulls Fax Rule
Endo Pharmaceuticals Inc. fired back Friday at the medical group leading a proposed class action alleging the company violated junk fax laws under the Telephone Consumer Protection Act, telling a Pennsylvania federal judge it's offered no legitimate reason why an already-eight-month stay on the case shouldn't continue.
-
January 06, 2015
Endo TCPA Suit Paused While FCC Mulls Solicited Fax Regs
A Pennsylvania federal judge on Monday placed a proposed class action accusing Endo Pharmaceuticals Inc. of violating the Telephone Consumer Protection Act in an indefinite holding pattern until the Federal Communications Commission decides whether solicited faxes should require opt-out notices.
-
April 21, 2014
Endo Hit With TCPA Junk Fax Suit Over Unsolicited Drug Ads
A medical group practice filed a putative class action against Endo Pharmaceuticals Inc. in Pennsylvania federal court Monday, alleging the company violated junk fax laws under the Telephone Consumer Protection Act by sending out unsolicited faxes advertising the company's Lidoderm and Opana ER prescription pain relief drugs.